Tristar Wellness Solutions Inc. (TWSI) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Tristar Wellness Solutions Inc. (TWSI) trades at $0.002. TriStar Wellness Solutions, Inc. is a developer, marketer, and seller of wound care, skincare, and infection control medical devices. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for TWSI: TWSI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TWSI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on TWSI.
How is this calculated? →Tristar Wellness Solutions Inc. (TWSI) Healthcare & Pipeline Overview
TriStar Wellness Solutions, Inc., based in Portland, Oregon, focuses on developing and marketing specialized wound care, skincare, and infection control products, primarily targeting the healthcare, consumer, and military markets, while operating within the competitive landscape of specialty and generic drug manufacturers and navigating the complexities of the OTC market.
What Is the Investment Thesis for TWSI?
Investing in TriStar Wellness Solutions, Inc. presents significant risks due to its Chapter 7 bankruptcy filing in 2016 and its current status on the OTC market. The company's negative P/E ratio of -3252.45 and a beta of 9.91 indicate high volatility and poor profitability. While the company offers a range of wound care and skincare products, its financial instability and OTC listing raise concerns about long-term viability. Potential investors should carefully consider the risks associated with investing in a company with a history of bankruptcy and limited financial resources. The absence of a dividend yield further reduces the attractiveness of this investment.
Based on FMP financials and quantitative analysis
TWSI Key Highlights
Market capitalization of $0.00B indicates a lack of investor confidence and potential delisting concerns.
- P/E ratio of -3252.45 reflects significant losses and challenges in achieving profitability.
- Beta of 9.91 suggests extremely high volatility compared to the broader market.
- No dividend yield indicates that the company is not returning profits to shareholders.
- Chapter 7 bankruptcy filing in 2016 raises serious concerns about the company's financial stability and future prospects.
Who Are TWSI's Competitors?
TWSI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TWSI's Key Strengths?
Specialized product offerings in wound care and skincare.
- Proprietary Delivery Devise with Invertible Diaphragm technology.
- Established Beaute de Maman brand recognition.
What Are TWSI's Weaknesses?
Chapter 7 bankruptcy filing in 2016.
- OTC market listing indicates financial instability.
- Limited financial resources and market visibility.
What Could Drive TWSI Stock Higher?
Potential for new partnerships to expand market reach.
- Development of new products in wound care and skincare.
- Expansion into emerging markets with affordable solutions.
What Are the Key Risks for TWSI?
Financial-distress signal — its Altman Z-Score of -24.24 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger pharmaceutical companies.
- Regulatory scrutiny and compliance requirements.
- Pricing pressures and market volatility.
- Limited financial resources impacting research and development.
- Dependence on key personnel and management team.
What Are the Growth Opportunities for TWSI?
- Expansion of Wound Care Product Line: TriStar could focus on developing and marketing advanced wound care products, targeting the growing market for chronic wound management. The global wound care market is projected to reach $22 billion by 2028, driven by the rising prevalence of diabetes and obesity. By innovating in areas such as bioactive dressings and regenerative medicine, TriStar could capture a share of this expanding market. Timeline: 2-3 years for product development and market entry.
- Strategic Partnerships in Healthcare: Collaborating with hospitals, clinics, and long-term care facilities could provide TriStar with access to a broader customer base and enhance its market reach. Strategic partnerships can facilitate the adoption of TriStar's wound care and infection control products, particularly in settings where infection prevention is critical. Timeline: 1-2 years for establishing partnerships and integrating products into healthcare systems.
- Leveraging the Beaute de Maman Brand: TriStar could expand its Beaute de Maman skincare line for pregnant and nursing women, capitalizing on the growing demand for specialized skincare products in this demographic. The market for pregnancy skincare is driven by increasing awareness of the importance of safe and effective skincare during pregnancy. Timeline: 1-2 years for product development and marketing campaigns.
- Geographic Expansion into Emerging Markets: Entering emerging markets with a focus on affordable wound care solutions could provide TriStar with significant growth opportunities. Countries with developing healthcare systems often face challenges in wound management, creating a demand for cost-effective products. Timeline: 3-5 years for market entry and establishing distribution networks.
- Development of Over-the-Counter Itch Suppression Products: TriStar could invest in developing and marketing innovative over-the-counter itch suppression products, targeting the large and growing market for dermatological solutions. The increasing prevalence of skin conditions such as eczema and psoriasis is driving demand for effective itch relief products. Timeline: 1-2 years for product development and market launch.
What Are TWSI's Competitive Advantages?
- Specialized product offerings in wound care and skincare.
- Proprietary Delivery Devise with Invertible Diaphragm technology.
- Established Beaute de Maman brand for pregnant and nursing women.
What Does TWSI Do?
TriStar Wellness Solutions, Inc., formerly known as BioPack Environmental Solutions, Inc., rebranded in January 2013 to concentrate on the healthcare sector. The company develops, markets, and sells a range of products, including wound care solutions, skincare products under the Beaute de Maman brand for pregnant and nursing women, and bleeding and wound management products aimed at surgical, healthcare, consumer, and military applications. TriStar also develops the Delivery Devise with Invertible Diaphragm, a medical applicator designed for internal drug delivery without causing injury. Additionally, the company produces over-the-counter itch suppression products and various wound care and infection control medical devices. Despite its product offerings, TriStar Wellness Solutions filed for Chapter 7 bankruptcy on January 15, 2016, and currently operates on the OTC market. The company is based in Portland, Oregon, and manages its operations with approximately 35 employees.
What Products and Services Does TWSI Offer?
- Develops and markets wound care products.
- Offers skincare products under the Beaute de Maman brand for pregnant and nursing women.
- Provides bleeding and wound management products for surgical, healthcare, consumer, and military markets.
- Develops and markets the Delivery Devise with Invertible Diaphragm for internal drug delivery.
- Produces over-the-counter itch suppression products.
- Manufactures and markets wound care and infection control medical devices.
How Does TWSI Make Money?
- Develops and manufactures specialized healthcare products.
- Markets and sells products directly to consumers and healthcare providers.
- Generates revenue through product sales in wound care, skincare, and infection control markets.
What Industry Does TWSI Operate In?
TriStar Wellness Solutions operates within the competitive specialty and generic drug manufacturing industry. This sector is characterized by intense competition, regulatory scrutiny, and the need for continuous innovation. Companies in this industry face challenges such as patent expirations, pricing pressures, and the rising costs of research and development. TriStar's position in the OTC market further complicates its competitive landscape, as it must navigate the challenges of limited resources and visibility compared to larger, exchange-listed peers. The industry is also influenced by trends in healthcare spending, aging populations, and increasing demand for advanced wound care and skincare solutions.
Who Are TWSI's Key Customers?
- Hospitals and clinics
- Healthcare providers
- Consumers
- Military markets
Key Financial Metrics
Return on equity for Tristar Wellness Solutions Inc. stands at 0.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.6%, showing how much profit it generates from its asset base. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -10.5%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Tristar Wellness Solutions Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Portland, US. The company is led by CEO David Duarte. TWSI has traded publicly since 2006.
Financial Health
Tristar Wellness Solutions Inc.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -24.24 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
The most recent 5 insider filings for Tristar Wellness Solutions Inc. break down as 2 sales and 3 purchases. On net that is roughly 2.2M shares acquired (about $0) — insiders putting money in tends to read as conviction.
TWSI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that executives believe in the growth potential.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative wellness products gaining traction.
- Positive media coverage around wellness trends has amplified interest in Tristar, positioning it as a leader in a growing market.
- Increased engagement on social platforms shows a rising number of retail investors supporting the brand and its mission.
Bear Case
- Some analysts express concerns about the company's ability to scale operations effectively in a competitive wellness market.
- Recent negative sentiment from a portion of the community points to skepticism about the sustainability of Tristar's growth amidst economic uncertainty.
- There are worries regarding potential regulatory challenges that could impact product offerings and market access.
- Market perception remains cautious due to previous volatility in the wellness sector, leading to hesitance among traditional investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TWSI Latest News
No recent news available for TWSI.
TWSI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TWSI.
Price Targets
Wall Street price target analysis for TWSI.
TWSI MoonshotScore
What does this score mean?
The MoonshotScore rates TWSI 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Robert Ramsey
CEO
Robert Ramsey is the CEO of TriStar Wellness Solutions, Inc., overseeing the company's operations and strategic direction. His background includes managing teams of approximately 35 employees and guiding the company through its product development and marketing efforts. Additional details regarding his specific career history, education, and previous roles are not available.
Track Record: Under Robert Ramsey's leadership, TriStar Wellness Solutions has focused on developing and marketing specialized wound care, skincare, and infection control products. However, the company filed for Chapter 7 bankruptcy in 2016, indicating significant financial challenges during his tenure. Further details on specific achievements and strategic decisions are not available.
TWSI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for trading on OTCQX or OTCQB. These securities often include those of companies that are distressed, in bankruptcy, or unwilling or unable to meet the minimum financial and disclosure requirements of the higher tiers. Investing in OTC Other securities carries substantial risks due to the limited information available and the potential for fraud or manipulation. These stocks may have very thin trading volume and wide bid-ask spreads.
- OTC Tier: OTC Other
- Limited or no financial disclosure increases the risk of fraud or mismanagement.
- Low trading volume and wide bid-ask spreads make it difficult to buy or sell shares.
- OTC Other status indicates significant financial distress or non-compliance.
- Potential for pump-and-dump schemes and market manipulation.
- Bankruptcy history raises concerns about long-term viability.
- Verify the company's current legal status and compliance with regulations.
- Attempt to obtain any available financial statements, even if unaudited.
- Research the background and reputation of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC Other securities.
- Consult with a qualified financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Presence of a functional website, although this does not guarantee legitimacy.
- Continued operation despite past bankruptcy, indicating some level of ongoing business activity.
- Listing on OTC markets, providing a platform for trading, however risky.
What Investors Ask About Tristar Wellness Solutions Inc. (TWSI) — Healthcare
What does Tristar Wellness Solutions Inc. do?
TriStar Wellness Solutions, Inc. develops, markets, and sells a range of healthcare products, primarily focusing on wound care, skincare, and infection control. Their product line includes specialized wound care solutions, skincare products under the Beaute de Maman brand for pregnant and nursing women, and bleeding and wound management products. The company also develops the Delivery Devise with Invertible Diaphragm.
What do analysts say about TWSI stock?
There is currently no available analyst coverage or consensus on TriStar Wellness Solutions Inc. (TWSI) due to its OTC listing and past bankruptcy. Key valuation metrics such as price targets and earnings estimates are not available.
What are the main risks for TWSI?
The main risks for TriStar Wellness Solutions Inc. include its Chapter 7 bankruptcy filing in 2016, which raises concerns about its long-term financial viability. Its OTC market listing indicates limited financial resources and regulatory compliance challenges. The company faces intense competition from larger pharmaceutical companies and is subject to regulatory scrutiny and pricing pressures. Additionally, the company's limited financial disclosure increases the risk of fraud or mismanagement.
What are the key factors to evaluate for TWSI?
Evaluate TWSI on fundamentals, analyst consensus, and risk factors. Investing in TriStar Wellness Solutions, Inc. presents significant risks due to its Chapter 7 bankruptcy filing in 2016 and its current status on the OTC market. Not financial advice.
How frequently does TWSI data refresh on this page?
TWSI's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TWSI's recent stock price performance?
Tristar Wellness Solutions Inc. (TWSI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product offerings in wound care and skincare. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TWSI overvalued or undervalued right now?
Tristar Wellness Solutions Inc. (TWSI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TWSI before investing?
Before investing in Tristar Wellness Solutions Inc. (TWSI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's OTC status and past bankruptcy.
- Financial data may not be current or readily available.
- AI analysis is pending.